Bayer AG, a German pharmaceutical and chemical company, is facing new challenges as it anticipates a decline in profits for the third consecutive year. The company is grappling with widespread legal disputes in the U.S., a steep drop in agricultural product prices, and increasing competition in the pharmaceutical market.